GYEONGGI-DO, South Korea & GAITHERSBURG, Md., August 21, 2024--(BUSINESS WIRE)--D&D Pharmatech, Inc. (D&D) (KOSDAQ: 347850), a clinical-stage biotechnology company focused on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback